Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions
Top Cited Papers
- 1 April 2007
- journal article
- research article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 45 (4) , 645-654.e1
- https://doi.org/10.1016/j.jvs.2006.12.054
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Cholesterol Reduction With Atorvastatin Improves Walking Distance in Patients With Peripheral Arterial DiseaseCirculation, 2003
- Statin Use and Leg Functioning in Patients With and Without Lower-Extremity Peripheral Arterial DiseaseCirculation, 2003
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialPublished by Elsevier ,2002
- MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experiencePublished by Oxford University Press (OUP) ,1999
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Peripheral Arterial Disease in the ElderlyArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Edinburgh Artery Study: Prevalence of Asymptomatic and Symptomatic Peripheral Arterial Disease in the General PopulationInternational Journal of Epidemiology, 1991
- The prevalence of peripheral arterial disease in a defined population.Circulation, 1985
- Serum cholesterol, other risk factors, and cardiovascular disease in a Japanese cohortJournal of Chronic Diseases, 1984